This activation fosters the formation of foam cells and exacerbates endothelial dysfunction, ultimately promoting plaque destabilization.170 On the other hand, ILC3s, with their production of IL-17A and IL-22, further intensify the inflammatory environment within arterial walls. This evidence concerns the gene IL17A and endothelial dysfunction.